NCT02804594View on ClinicalTrials.gov

A Study of Oxidative Pathways in MS Fatigue

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 1, 2016

Primary Completion Date

June 1, 2018

Study Completion Date

June 1, 2018

Conditions
Progressive Multiple SclerosisFatigue
Interventions
DRUG

N-acetyl cysteine

1250 mg of N- acetyl cysteine taken three times daily

DRUG

Placebo

placebo taken three times daily

Trial Locations (1)

94158

University of California San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT02804594 - A Study of Oxidative Pathways in MS Fatigue | Biotech Hunter | Biotech Hunter